Mitochondrial DNA disease—molecular insights and potential routes to a cure
Open Access
- 1 July 2014
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 325 (1) , 38-43
Abstract
No abstract availableKeywords
Funding Information
- Newcastle University Centre for Brain Ageing and Vitality (G0700718)
- Newcastle upon Tyne Hospitals NHS Foundation Trust
- MRC Centre for Neuromuscular Disease (G000608-1)
- Wellcome Trust Centre for Mitochondrial Research (096919/Z/11/Z)
- The Lily Foundation
- UK NHS Specialist Commissioners “Rare Mitochondrial Disorders of Adults and Children” Service
This publication has 40 references indexed in Scilit:
- Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENsNature Medicine, 2013
- Genetic engineering of human pluripotent cells using TALE nucleasesNature Biotechnology, 2011
- Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNANucleic Acids Research, 2008
- Two ways to make an mtDNA bottleneckNature Genetics, 2008
- Homoplasmy, heteroplasmy, and mitochondrial dystoniaNeurology, 2007
- Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylaseProceedings of the National Academy of Sciences, 2006
- Mitochondrial DNA mutations in human diseaseNature Reviews Genetics, 2005
- Gene Therapy for Mitochondrial Disease by Delivering Restriction Endonuclease SmaI into MitochondriaJournal of Biomedical Science, 2002
- Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNALys with the MERRF encephalomyopathy pathogenic mutationFEBS Letters, 2000
- Peptide nucleic acid delivery to human mitochondriaGene Therapy, 1999